WHO gives further support to Bavarian Nordic and Johnson & Johnson's Ebola vaccine
A WHO committee has updated its recommendations with good news for Johnson & Johnson and Bavarian Nordic's two-dose Ebola vaccine.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
The latest recommendations from the World Health Organization (WHO) support the use of Johnson & Johnson and Bavarian Nordic's two-dose vaccine regimen against Ebola virus, according to a Monday press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
